Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,593 | 0 | 0 | N/A | 0 |
| Marketable Securities | 239,248 | 0 | 0 | N/A | 0 |
| Other current assets | 577 | 0 | 0 | 0 | 0 |
| TOTAL | $297,364 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 10,984 | N/A | N/A | N/A | N/A |
| Investments And Advances | 187,464 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,549 | 0 | 0 | 0 | 0 |
| TOTAL | $209,997 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $507,361 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,979 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 7,874 | 0 | 0 | N/A | 0 |
| TOTAL | $107,286 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 92,011 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 14,327 | 0 | 0 | 0 | 0 |
| TOTAL | $105,390 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $212,676 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,459 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | 0 | 0 | N/A | 0 |
| Retained earnings | -116,080 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | -164 | 0 | 0 | 0 | 0 |
| TOTAL | $294,685 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $507,361 | $0 | $0 | $0 | $0 |